Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [847]

Ribociclib improves progression-free survival in advanced breast cancer

Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center...

Ribociclib improves progression-free survival in advanced breast cancer ( Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center, Houston, US )

Omics, early detection and novel therapies: Metabolomics

Dr Olivier Pardo - Imperial College London, London, UK

Omics, early detection and novel therapies: Metabolomics ( Dr Olivier Pardo - Imperial College London, London, UK )

Editor's Choice for September 2016

Prof Gordon McVie - Editor in Chief, ecancer

Editor's Choice for September 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )

Better screening programmes needed for haematological malignancies such as...

Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany

Better screening programmes needed for haematological malignancies such as leukaemia ( Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany )

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )

Direct activation of STING in the tumour microenvironment leads to potent and...

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )

Multi-target S-DNA increases colorectal cancer screening among previously non...

Dr Barry Berger - Exact Sciences, Madison, USA

Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients ( Dr Barry Berger - Exact Sciences, Madison, USA )

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Dr Andrea Califano - Colombia University Medical Centre, New York, USA

Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )

Non-coding mutations driving chronic lymphocytic leukaemia

Dr Xose Puente - University of Oviedo, Oviedo, Spain

Non-coding mutations driving chronic lymphocytic leukaemia ( Dr Xose Puente - University of Oviedo, Oviedo, Spain )

Next-generation sequencing in the lymphoid malignancies

Dr Aaron Logan - UCSF, San Fransisco, USA

Next-generation sequencing in the lymphoid malignancies ( Dr Aaron Logan - UCSF, San Fransisco, USA )

More from ecancer